Colony Group LLC Meridian Bioscience Inc Transaction History

Colony Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$23.75 - $31.69 $438,472 - $585,060	-18,462 Reduced 11.1%	147,902 $4.5 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $16,734 - $22,575	838 Added 0.51%	166,364 $4.32 Million
Q4 2021 Feb 15, 2022	BUY	$17.46 - $21.61 $200,650 - $248,342	11,492 Added 7.46%	165,526 $3.38 Million
Q3 2021 Nov 17, 2021	BUY	$17.35 - $22.5 $91,087 - $118,125	5,250 Added 3.53%	154,034 $2.96 Million
Q2 2021 Aug 18, 2021	BUY	$18.01 - $28.32 $27,843 - $43,782	1,546 Added 1.05%	148,784 $3.3 Million
Q1 2021 May 21, 2021	BUY	$19.76 - $29.89 $283,990 - $429,579	14,372 Added 10.82%	147,238 $3.87 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $292,404 - $402,637	-18,589 Reduced 12.27%	132,866 $2.48 Million
Q3 2020 Nov 17, 2020	BUY	$13.54 - $26.41 $2.05 Million - $4 Million	151,455 New	151,455 $2.57 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.